Treatment of generalized tardive dystonia with clozapine

Psychiatria Danubina

Volumn 20, Issue 3, 2008, Pages 329-331

  Aukst Margetić, Branka ^a   Margetić, Branimir ^a  

^a Neuropsihijatrijska bolnica   (Croatia)

Author keywords

Antipsychotic; Clozapine; Tardive dystonia; Treatment

Indexed keywords

BIPERIDEN; CLOZAPINE; DIAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; PROPRANOLOL; RISPERIDONE;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSTONIA; HALLUCINATION; HUMAN; MALE; PHYSIOTHERAPY; PSYCHOSIS; RETREATMENT; SCHIZOPHRENIA; TREATMENT OUTCOME; TREMOR;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DYSKINESIA, DRUG-INDUCED; DYSTONIC DISORDERS; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GABA; RECEPTORS, MUSCARINIC; RISPERIDONE;

EID: 54349124776     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Adityanjee, Aderibigbe YA, Chowdary Jampala V, Mathews T. The current status of tardive dystonia. Biological psychiatry 1999;45:715-730.
2. Ahmed S, Chengappa KNR, Naidu VR, Baker RW, Parepally H, Schooler NR. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series. Journal of Clinical Psychiatry. 1998; 59:472- 477.
3. Buckley PF. Receptor-binding profiles of antipsychotics: Clinical strategies when switching between agents. Journal of Clinical Psychiatry 2007; 68(suppl 6): 5-9.
4. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35:73-77.
5. Dunayevich E, Strakowski SM. Olanzapine-induced tardive dystonia. American Journal of Psychiatry 1999;156:1662.
6. Garcia-Lado I, Garcia-Caballero A, Recimil JM, Area R, Ozaita G, Lamas S. Reapperance of tardive dystonia with olanzapine treated with clozapine. Schizophrenia Research 2005; 76:357-358.
7. Havaki-Kontaxaki BJ, Kontaxakis VP, Christodoulou GN. (2004). Treatment of tardive pharyngolaryngeal dystonia with olanzapine. Schizophrenia Research; 66: 199-200.
8. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13:261-276.
9. Krebs MO, Olie JP. Tardive dystonia induced by risperidone. Canadian Journal of Psychiatry 1999; 44: 507-508.
10. Lieberman J, Saltz B, Johns C, Pollack S, Borenstein M, Kane J. The effects of clozapine on tardive dyskinesia. British Journal of Psychiatry 1991;158:503-510.
11. Maršálek M. Tardive drug-induced extrapyramidal syndromes. Pharmacopsychiatry 2000;33 (Suppl 1):14-33.
12. Molho ES, Factor SA. Possible tardive dystonia resulting from clozapine therapy. Movement disorders 1999;14: 873-874.
13. Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Molecular Psychiatry 1998;3:123-134.
14. Scott BL. Evaluation and Treatment of Dysonia. Southern Medical Journal. 2000; 93: 745-751.
15. Trugman JM, Leadbetter R, Zalis ME. Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis. Movement disorders 1994;9:441-446.
16. van Harten PN, Kahn RS. Tardive dystonia. Schizophrenia Bulletin 1999; 25:741-748.